East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Clindamycin Phosphate Gel. Aurobindo Pharma’s Clindamycin Phosphate Gel, is an AB-rated generic equivalent to the reference listed drug (RLD), Cleocin^®  T Gel, manufactured by Pfizer Inc.

Clindamycin Phosphate Gel are indicated:

• In the treatment of acne vulgaris.